Professor & Vice Chair, Laboratory Medicine, and Medical Director of Clinical Laboratories & Molecular Pathology, Medical University of South Carolina
BIOGRAPHY
AUG 24, 2021 4:00 PM CEST
HELP PROTECT WHAT MATTERS: DESIGN AND PERFORMANCE OF ALINITY M TRANSPLANT ASSAYS (CMV AND EBV)
Speaker
Event Date & Time
Date: August 24, 2021
Time: 2:00pm GMT, 4:00Pm CEST
Abstract
Cytomegalovirus (CMV) and Epstein Barr Virus (EBV) are found in high global seroprevalence. Infections usually are asymptomatic or manifest as mild or subclinical disease in immunocompetent individuals and establish life-long latency without causing serious health problems. However, in immunocompromised patients such as transplant recipients, reactivation of latent virus can result in severe disease. Patient monitoring, including quantitative nucleic acid testing (QNAT), may play an important role in patient management. Alinity m CMV and Alinity m EBV assays are quantitative in vitro polymerase chain reaction assays with a dual-target design to aid in redundancy in detection. This webinar will discuss the design and performance of the Alinity m CMV and Alinity m EBV assays.
Learning Objectives
- Review CMV & EBV Disease and Current Challenges
- Review the Alinity m CMV & EBV Assay Design
- Review Alinity m CMV & EBV Assay Clinical Performance
Alinity m CMV and Alinity m EBV assays are CE-marked. Check with your local representative for availability in specific markets.
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Loading Comments...